Skip to main content

Ciprofloxacin Extended-Release Tablets

Type of Posting: Revision Bulletin

Posting Date: 26–Jul–2013

Official Date: 01–Aug–2013

Archive Date: 09–Feb–2015

Expert Committee: Monographs—Small Molecules 1

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010-2015 Council of Experts, the Monographs—Small Molecules 1 Expert Committee has revised the Ciprofloxacin Extended-Release Tablets monograph. The purpose for the revision is to include Dissolution Test 2, based on the specifications approved by FDA.

The Ciprofloxacin Extended-Release Tablets Revision Bulletin replaces the monograph in First Supplement to USP 36–NF 31, which is scheduled to become official August 1, 2013. The Revision Bulletin will be incorporated in to USP 37–NF 32, Supplement 1.

Should you have any questions, please contact Shankari Shivaprasad, Ph.D. (301-230-7426 or sns@usp.org).